Original Sermorelin: Discovery & Research History
Sermorelin (GHRH(1-29) Fragment) — how it was originally developed, and what it has been studied for since.
How Sermorelin Was Discovered
Sermorelin is a synthetic fragment corresponding to the first 29 amino acids of native growth-hormone-releasing hormone — GHRH(1-29) — retaining the full receptor-binding bioactivity of the native hormone in a shorter, synthesizable form.
Its main limitation was always pharmacokinetic rather than pharmacological: sermorelin is cleared from circulation quickly, which is precisely why later analogs like CJC-1295 and Tesamorelin were engineered with additional stability modifications for a longer half-life. Sermorelin represents the foundational, unmodified GHRH signal that those later compounds were built to improve on.
What Sermorelin Has Been Studied For
Unlike most compounds referenced on this site, sermorelin has a completed pediatric approval history. The pivotal trials supporting its FDA approval as Geref (in prepubertal children with idiopathic GH deficiency) found daily subcutaneous sermorelin increased height velocity significantly, sustained through 36 months of continuous therapy. Geref was FDA-approved in 1990 and later discontinued from the market in 2008 for commercial, not safety, reasons.
- GHRH(1-29) receptor-agonism research
- Pediatric growth-hormone deficiency research
- Comparative GH-axis half-life studies
Read our GHRH & Growth Hormone research overview →
Sermorelin discovery & history questions
Does Sermorelin's research history mean it's approved for a particular use?
No. This page describes how Sermorelin was originally developed and what it has been studied for since — it is historical and educational context, not a claim about current regulatory approval, safety, or legal status anywhere. Any Sermorelin sourced through KYIN Peptides is for laboratory research use only.
What has Sermorelin been studied for in research?
Sermorelin is studied for GHRH-receptor agonism in growth-hormone research, and was formerly FDA-approved as Geref for pediatric growth hormone deficiency.
Interested in sourcing Sermorelin?
Not part of our standard catalogue, but available to order — contact us and we'll help you source it.